Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Adam Stoten

Adam is the Chief Operating Officer and board director at Oxford University Innovation, OUI, with overall operational responsibility for the Licensing & Ventures and Consulting Services activities. Adam previously led the Life Sciences Licensing & Ventures Group at OUI, where he oversaw the formation of more than 20 new spin out companies and led the creation of LAB282, a £13M partnership with Oxford Sciences Innovation plc and Evotec AG to accelerate Oxford drug discovery activities.

He has more than 15 years in commercial roles encompassing business development and licensing, new venture formation, product development, lobbying/advocacy and general management.